|
Re: Thoughts on ZCC
|
8
|
Zenith Epigenetics
|
Sep 04, 2021 11:02AM
|
|
Re: Thoughts on ZCC
|
3
|
Zenith Epigenetics
|
Sep 03, 2021 10:01AM
|
|
Re: Trillium
|
5
|
Zenith Epigenetics
|
Aug 26, 2021 11:25AM
|
|
Re: Trillium
|
6
|
Zenith Epigenetics
|
Aug 26, 2021 09:32AM
|
|
Re: Zenith Email this morning
|
6
|
Zenith Epigenetics
|
Aug 17, 2021 10:34AM
|
|
inexpensive anti depressant could be best covid treatment
|
7
|
Resverlogix Corp.
|
Aug 12, 2021 04:05PM
|
|
Re: Shareholder Value
|
6
|
Zenith Epigenetics
|
Aug 06, 2021 10:09PM
|
|
Re: New video
|
3
|
Resverlogix Corp.
|
Aug 03, 2021 11:47AM
|
|
Re: No word on...
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 10:59AM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
6
|
Resverlogix Corp.
|
Jul 09, 2021 10:30AM
|
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
6
|
Zenith Epigenetics
|
Jun 05, 2021 02:13PM
|
|
Re: Zenith Epigenetics did not respond to invitatations in this one
|
4
|
Zenith Epigenetics
|
May 31, 2021 01:14PM
|
|
Re: HL Acquires Additional Securities of RVX
|
5
|
Resverlogix Corp.
|
May 22, 2021 12:58PM
|
|
Re: HL Acquires Additional Securities of RVX
|
8
|
Resverlogix Corp.
|
May 22, 2021 11:26AM
|
|
Sophisticated investment group
|
2
|
Resverlogix Corp.
|
May 17, 2021 08:43PM
|
|
Re: A new day for RVX
|
6
|
Resverlogix Corp.
|
May 13, 2021 10:42AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
8
|
Resverlogix Corp.
|
May 03, 2021 06:40PM
|
|
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
4
|
Resverlogix Corp.
|
Apr 27, 2021 04:02PM
|
|
Re: Cancer research derailed by nearly two years due to COVID-19, scientists say.
|
5
|
Zenith Epigenetics
|
Apr 26, 2021 05:58PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
1
|
Resverlogix Corp.
|
Apr 21, 2021 11:46AM
|
